Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

Human small bowel as model for poisoning with organophosphorus compounds.

Marquart K, Prokopchuk O, Wilhelm D, Worek F, Thiermann H, Martignoni ME, Wille T.

Toxicol In Vitro. 2019 Jun;57:76-80. doi: 10.1016/j.tiv.2019.02.010. Epub 2019 Feb 11.

PMID:
30763608
2.

Influence of Access Cavity Preparation and Remaining Tooth Substance on Fracture Strength of Endodontically Treated Teeth.

Corsentino G, Pedullà E, Castelli L, Liguori M, Spicciarelli V, Martignoni M, Ferrari M, Grandini S.

J Endod. 2018 Sep;44(9):1416-1421. doi: 10.1016/j.joen.2018.05.012. Epub 2018 Jul 23.

PMID:
30049468
3.

Nutritional support and therapy in pancreatic surgery: A position paper of the International Study Group on Pancreatic Surgery (ISGPS).

Gianotti L, Besselink MG, Sandini M, Hackert T, Conlon K, Gerritsen A, Griffin O, Fingerhut A, Probst P, Abu Hilal M, Marchegiani G, Nappo G, Zerbi A, Amodio A, Perinel J, Adham M, Raimondo M, Asbun HJ, Sato A, Takaori K, Shrikhande SV, Del Chiaro M, Bockhorn M, Izbicki JR, Dervenis C, Charnley RM, Martignoni ME, Friess H, de Pretis N, Radenkovic D, Montorsi M, Sarr MG, Vollmer CM, Frulloni L, Büchler MW, Bassi C.

Surgery. 2018 Nov;164(5):1035-1048. doi: 10.1016/j.surg.2018.05.040. Epub 2018 Jul 17.

PMID:
30029989
4.

Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial.

Choueiri TK, Larkin J, Oya M, Thistlethwaite F, Martignoni M, Nathan P, Powles T, McDermott D, Robbins PB, Chism DD, Cho D, Atkins MB, Gordon MS, Gupta S, Uemura H, Tomita Y, Compagnoni A, Fowst C, di Pietro A, Rini BI.

Lancet Oncol. 2018 Apr;19(4):451-460. doi: 10.1016/S1470-2045(18)30107-4. Epub 2018 Mar 9.

PMID:
29530667
5.

Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.

Prokopchuk O, Grünwald B, Nitsche U, Jäger C, Prokopchuk OL, Schubert EC, Friess H, Martignoni ME, Krüger A.

BMC Cancer. 2018 Feb 2;18(1):128. doi: 10.1186/s12885-018-4055-9.

6.

[Peri- and postoperative nutrition in colorectal cancer patients].

Reischl S, Wilhelm DF, Neumann PA, Friess H, Martignoni ME.

Ther Umsch. 2018;75(10):642-648. doi: 10.1024/0040-5930/a001052. German.

PMID:
31232664
7.
8.

Human small bowel as a useful tool to investigate smooth muscle effects of potential therapeutics in organophosphate poisoning.

Marquart K, Prokopchuk O, Worek F, Thiermann H, Martignoni ME, Wille T.

Toxicol Lett. 2018 Sep 1;293:235-240. doi: 10.1016/j.toxlet.2017.11.012. Epub 2017 Nov 14.

PMID:
29154801
9.

3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer.

Lutz MP, Zalcberg JR, Ducreux M, Aust D, Bruno MJ, Büchler MW, Delpero JR, Gloor B, Glynne-Jones R, Hartwig W, Huguet F, Laurent-Puig P, Lordick F, Maisonneuve P, Mayerle J, Martignoni M, Neoptolemos J, Rhim AD, Schmied BM, Seufferlein T, Werner J, van Laethem JL, Otto F.

Eur J Cancer. 2017 Jul;79:41-49. doi: 10.1016/j.ejca.2017.03.022. Epub 2017 Apr 29.

10.

The clinical picture of cachexia: a mosaic of different parameters (experience of 503 patients).

Schwarz S, Prokopchuk O, Esefeld K, Gröschel S, Bachmann J, Lorenzen S, Friess H, Halle M, Martignoni ME.

BMC Cancer. 2017 Feb 14;17(1):130. doi: 10.1186/s12885-017-3116-9.

11.

Inhibition of the Cysteine Protease Human Cathepsin L by Triazine Nitriles: Amide⋅⋅⋅Heteroarene π-Stacking Interactions and Chalcogen Bonding in the S3 Pocket.

Giroud M, Ivkovic J, Martignoni M, Fleuti M, Trapp N, Haap W, Kuglstatter A, Benz J, Kuhn B, Schirmeister T, Diederich F.

ChemMedChem. 2017 Feb 3;12(3):257-270. doi: 10.1002/cmdc.201600563. Epub 2017 Jan 12.

PMID:
27992115
12.

IL-4 mRNA Is Downregulated in the Liver of Pancreatic Cancer Patients Suffering from Cachexia.

Prokopchuk O, Steinacker JM, Nitsche U, Otto S, Bachmann J, Schubert EC, Friess H, Martignoni ME.

Nutr Cancer. 2017 Jan;69(1):84-91. doi: 10.1080/01635581.2017.1247885. Epub 2016 Nov 29.

PMID:
27897439
13.

Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry.

Bassani-Sternberg M, Bräunlein E, Klar R, Engleitner T, Sinitcyn P, Audehm S, Straub M, Weber J, Slotta-Huspenina J, Specht K, Martignoni ME, Werner A, Hein R, H Busch D, Peschel C, Rad R, Cox J, Mann M, Krackhardt AM.

Nat Commun. 2016 Nov 21;7:13404. doi: 10.1038/ncomms13404.

14.

Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.

Grünwald B, Harant V, Schaten S, Frühschütz M, Spallek R, Höchst B, Stutzer K, Berchtold S, Erkan M, Prokopchuk O, Martignoni M, Esposito I, Heikenwalder M, Gupta A, Siveke J, Saftig P, Knolle P, Wohlleber D, Krüger A.

Gastroenterology. 2016 Nov;151(5):1011-1024.e7. doi: 10.1053/j.gastro.2016.07.043. Epub 2016 Aug 6.

PMID:
27506299
15.

Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?

Mueller TC, Bachmann J, Prokopchuk O, Friess H, Martignoni ME.

BMC Cancer. 2016 Feb 8;16:75. doi: 10.1186/s12885-016-2121-8. Review.

16.

Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.

Sartore-Bianchi A, Ardini E, Bosotti R, Amatu A, Valtorta E, Somaschini A, Raddrizzani L, Palmeri L, Banfi P, Bonazzina E, Misale S, Marrapese G, Leone A, Alzani R, Luo D, Hornby Z, Lim J, Veronese S, Vanzulli A, Bardelli A, Martignoni M, Davite C, Galvani A, Isacchi A, Siena S.

J Natl Cancer Inst. 2015 Nov 12;108(1). pii: djv306. doi: 10.1093/jnci/djv306. Print 2016 Jan.

17.

Influence of an elevated nutrition risk score (NRS) on survival in patients following gastrectomy for gastric cancer.

Bachmann J, Müller T, Schröder A, Riediger C, Feith M, Reim D, Friess H, Martignoni ME.

Med Oncol. 2015 Jul;32(7):204. doi: 10.1007/s12032-015-0631-x. Epub 2015 Jun 13.

PMID:
26071123
18.

Genetic analysis of circulating tumor cells in pancreatic cancer patients: A pilot study.

Görner K, Bachmann J, Holzhauer C, Kirchner R, Raba K, Fischer JC, Martignoni ME, Schiemann M, Alunni-Fabbroni M.

Genomics. 2015 Jul;106(1):7-14. doi: 10.1016/j.ygeno.2015.02.003. Epub 2015 Mar 24.

19.

Cachexia and pancreatic cancer: are there treatment options?

Mueller TC, Burmeister MA, Bachmann J, Martignoni ME.

World J Gastroenterol. 2014 Jul 28;20(28):9361-73. doi: 10.3748/wjg.v20.i28.9361. Review.

20.

Hepatic transforming growth factor-β 1 stimulated clone-22 D1 controls systemic cholesterol metabolism.

Jäger J, Greiner V, Strzoda D, Seibert O, Niopek K, Sijmonsma TP, Schäfer M, Jones A, De Guia R, Martignoni M, Dallinga-Thie GM, Diaz MB, Hofmann TG, Herzig S.

Mol Metab. 2014 Jan 8;3(2):155-66. doi: 10.1016/j.molmet.2013.12.007. eCollection 2014 Apr.

21.

Motor protein function in skeletal abdominal muscle of cachectic cancer patients.

Taskin S, Stumpf VI, Bachmann J, Weber C, Martignoni ME, Friedrich O.

J Cell Mol Med. 2014 Jan;18(1):69-79. doi: 10.1111/jcmm.12165. Epub 2013 Nov 19.

22.

First experience with image-guided resection of paraganglioma.

Einspieler I, Novotny A, Okur A, Essler M, Martignoni ME.

Clin Nucl Med. 2014 Aug;39(8):e379-81. doi: 10.1097/RLU.0000000000000239.

PMID:
24217546
23.

Transferring innovative freehand SPECT to the operating room: first experiences with sentinel lymph node biopsy in malignant melanoma.

Mihaljevic AL, Rieger A, Belloni B, Hein R, Okur A, Scheidhauer K, Schuster T, Friess H, Martignoni ME.

Eur J Surg Oncol. 2014 Jan;40(1):42-8. doi: 10.1016/j.ejso.2013.09.005. Epub 2013 Sep 17.

PMID:
24084086
24.

Cachexia in patients with chronic pancreatitis and pancreatic cancer: impact on survival and outcome.

Bachmann J, Büchler MW, Friess H, Martignoni ME.

Nutr Cancer. 2013;65(6):827-33. doi: 10.1080/01635581.2013.804580.

PMID:
23909726
25.

Immediate loading of Brånemark system TiUnite and machined-surface implants in the posterior mandible, part II: a randomized open-ended 9-year follow-up clinical trial.

Rocci A, Rocci M, Rocci C, Scoccia A, Gargari M, Martignoni M, Gottlow J, Sennerby L.

Int J Oral Maxillofac Implants. 2013 May-Jun;28(3):891-5. doi: 10.11607/jomi.2397.

PMID:
23748324
26.

A review of computer-based simulators for ultrasound training.

Blum T, Rieger A, Navab N, Friess H, Martignoni M.

Simul Healthc. 2013 Apr;8(2):98-108. doi: 10.1097/SIH.0b013e31827ac273. Review.

PMID:
23334364
27.
28.

Real-imaging cDNA-AFLP transcript profiling of pancreatic cancer patients: Egr-1 as a potential key regulator of muscle cachexia.

Skorokhod A, Bachmann J, Giese NA, Martignoni ME, Krakowski-Roosen H.

BMC Cancer. 2012 Jun 21;12:265. doi: 10.1186/1471-2407-12-265.

29.

Total gastric necrosis subsequent to acute pancreatitis.

Rieger A, Bachmann J, Schulte-Frohlinde E, Burzin M, Nährig J, Friess H, Martignoni ME.

Pancreas. 2012 Mar;41(2):325-7. doi: 10.1097/MPA.0b013e318227b04b. No abstract available.

PMID:
22343979
30.

[Augmented reality: merge of reality and virtuality in medicine].

Rieger A, Blum T, Navab N, Friess H, Martignoni ME.

Dtsch Med Wochenschr. 2011 Nov;136(47):2427-33. doi: 10.1055/s-0031-1292814. Epub 2011 Nov 17. Review. German. No abstract available.

PMID:
22094972
31.

First Experiences with Navigated Radio-Guided Surgery Using Freehand SPECT.

Rieger A, Saeckl J, Belloni B, Hein R, Okur A, Scheidhauer K, Wendler T, Traub J, Friess H, Martignoni ME.

Case Rep Oncol. 2011 May;4(2):420-5. doi: 10.1159/000330273. Epub 2011 Aug 30.

32.

A proposal for a new clinical classification of chronic pancreatitis.

Büchler MW, Martignoni ME, Friess H, Malfertheiner P.

BMC Gastroenterol. 2009 Dec 14;9:93. doi: 10.1186/1471-230X-9-93.

33.

Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.

Bachmann J, Ketterer K, Marsch C, Fechtner K, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME.

BMC Cancer. 2009 Jul 28;9:255. doi: 10.1186/1471-2407-9-255.

34.

Liver macrophages contribute to pancreatic cancer-related cachexia.

Martignoni ME, Dimitriu C, Bachmann J, Krakowski-Rosen H, Ketterer K, Kinscherf R, Friess H.

Oncol Rep. 2009 Feb;21(2):363-9.

PMID:
19148509
35.

Pleiotropic effects of spastin on neurite growth depending on expression levels.

Riano E, Martignoni M, Mancuso G, Cartelli D, Crippa F, Toldo I, Siciliano G, Di Bella D, Taroni F, Bassi MT, Cappelletti G, Rugarli EI.

J Neurochem. 2009 Mar;108(5):1277-88. doi: 10.1111/j.1471-4159.2009.05875.x. Epub 2009 Jan 29.

36.

[Molecular mechanisms and its clinical impact in cancer cachexia].

Bachmann J, Friess H, Martignoni ME.

Z Gastroenterol. 2008 Dec;46(12):1384-92. doi: 10.1055/s-2008-1027655. Epub 2008 Dec 3. Review. German.

PMID:
19053008
37.

Increased alternative splicing of the KLF6 tumour suppressor gene correlates with prognosis and tumour grade in patients with pancreatic cancer.

Hartel M, Narla G, Wente MN, Giese NA, Martignoni ME, Martignetti JA, Friess H, Friedman SL.

Eur J Cancer. 2008 Sep;44(13):1895-903. doi: 10.1016/j.ejca.2008.06.030. Epub 2008 Aug 6.

PMID:
18691883
38.

Optimal mechanical design of anatomical post-systems for endodontic restoration.

Maceri F, Martignoni M, Vairo G.

Comput Methods Biomech Biomed Engin. 2009 Feb;12(1):59-71. doi: 10.1080/10255840903065530.

PMID:
18629740
39.

The role of ZFYVE27/protrudin in hereditary spastic paraplegia.

Martignoni M, Riano E, Rugarli EI.

Am J Hum Genet. 2008 Jul;83(1):127-8; author reply 128-30. doi: 10.1016/j.ajhg.2008.05.014. No abstract available.

40.

Comparing the TiOblast and Osseospeed surfaces. Histomorphometric and histological analysis in humans.

Rocci M, Rocci A, Martignoni M, Albrektsson T, Barlattani A, Gargari M.

Oral Implantol (Rome). 2008 Apr;1(1):34-42. Epub 2008 Jun 16.

41.

Cachexia worsens prognosis in patients with resectable pancreatic cancer.

Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME.

J Gastrointest Surg. 2008 Jul;12(7):1193-201. doi: 10.1007/s11605-008-0505-z. Epub 2008 Mar 18.

PMID:
18347879
42.

Pancreatic resection for pancreatic cancer.

Bachmann J, Michalski CW, Martignoni ME, Büchler MW, Friess H.

HPB (Oxford). 2006;8(5):346-51. doi: 10.1080/13651820600803981. No abstract available.

43.

Activity of the Akt-dependent anabolic and catabolic pathways in muscle and liver samples in cancer-related cachexia.

Schmitt TL, Martignoni ME, Bachmann J, Fechtner K, Friess H, Kinscherf R, Hildebrandt W.

J Mol Med (Berl). 2007 Jun;85(6):647-54. Epub 2007 Mar 2. Erratum in: J Mol Med. 2007 Jun;85(6):655-6.

PMID:
17333095
44.

Mechanical behaviour of endodontic restorations with multiple prefabricated posts: a finite-element approach.

Maceri F, Martignoni M, Vairo G.

J Biomech. 2007;40(11):2386-98. Epub 2007 Jan 24.

PMID:
17254588
45.

Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction.

Martignoni M, Groothuis GM, de Kanter R.

Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):875-94. Review.

PMID:
17125407
46.

Randomized clinical trial of the influence of local water-filtered infrared A irradiation on wound healing after abdominal surgery.

Hartel M, Hoffmann G, Wente MN, Martignoni ME, Büchler MW, Friess H.

Br J Surg. 2006 Aug;93(8):952-60.

PMID:
16845694
47.

Clinical impact of cachexia on survival and outcome of cancer patients.

Dimitriu C, Martignoni ME, Bachmann J, Fröhlich B, Tintărescu G, Buliga T, Lică I, Constantinescu G, Beuran M, Friess H.

Rom J Intern Med. 2005;43(3-4):173-85. Review.

PMID:
16812978
48.

Comparison of mouse and rat cytochrome P450-mediated metabolism in liver and intestine.

Martignoni M, Groothuis G, de Kanter R.

Drug Metab Dispos. 2006 Jun;34(6):1047-54. Epub 2006 Mar 24.

PMID:
16565172
49.

[Cytokine traps: a new promising approach to treatment?].

Fröhlich B, Martignoni ME, Friess H.

Z Gastroenterol. 2003 Dec;41(12):1177-8. German. No abstract available.

PMID:
16335494
50.

Varying linezolid susceptibility of vancomycin-resistant Enterococcus faecium isolates during therapy: a case report.

Swoboda S, Fritz S, Martignoni ME, Feldhues RA, Hoppe-Tichy T, Buchler MW, Geiss HK.

J Antimicrob Chemother. 2005 Oct;56(4):787-9. Epub 2005 Sep 5.

PMID:
16143710

Supplemental Content

Loading ...
Support Center